Hikma Pharmaceuticals becomes Patron of The Prince’s Trust - Supporting young people into education and employment

London, 19 March 2018 – Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK), the multinational generic pharmaceutical company, announced today it has pledged £200,000 to The Prince’s Trust over the next four years to help disadvantaged young people gain new skills and life changing experience in the world of work. The partnership will support young people who face multiple barriers to access education and employment opportunities in the UK.

Press Release Corporate 19 March 2018

Hikma becomes a Patron of The Prince’s Trust in recognition of a generous commitment to fund The Prince’s Trust’s programmes and interventions, with a portion of funds focussed specifically on the area of STEM (Science, Technology, Engineering and Maths). The Prince’s Trust has been promoting the importance of these subjects and these disciplines are now embedded across its range of programmes, and it is also aligned with Hikma’s focus on empowering youth through providing educational opportunities.

“We have always believed we have a duty of care not just to the patients who use our medicines, but also to the communities in which we operate,” said Hana Ramadan, Vice President of Corporate Responsibility.  “We are delighted to become a Patron of the Prince’s Trust and support the important work they do with young people. Our growing London team looks forward to the numerous volunteering opportunities to help young people overcome barriers they face in education and work.”

The Prince’s Trust was founded by HRH The Prince of Wales in 1976 to promote social mobility and has returned £1.4 billion in value to society through its help for disadvantaged young people over the last ten years alone.

Tom Lamb, Senior Head of Business Development and Corporate Partnerships for The Prince’s Trust said, “We are immensely grateful to Hikma for their generosity. We’re excited to work with the business in the UK, engaging staff in volunteering and mentoring and inspiring young people to explore brand new career pathways. Together, we are giving disadvantaged young people new skills and opportunities to achieve their full potential.”

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.